Try
Teleflex Incorporated Common Stock
TFXUnited States
94 filed reports · 862 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
94 reports · Dec 2011 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 238 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 44 | 8,902 | Apr 2012 to Jun 2026 |
| Current · 8-KSEC EDGAR | 35 | 262 | Dec 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 15 | 10,116 | Dec 2011 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 14 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 391 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 255 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 1,225 | Open |
| FY2025 Q3 | 10-Q | Sep 28, 2025 | Nov 6, 2025 | 272 | Open |
| FY2025 Q2 | 10-Q | Jun 29, 2025 | Jul 31, 2025 | 159 | Open |
| FY2025 Q1 | 10-Q | Mar 30, 2025 | May 1, 2025 | 165 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 570 | Open |
| FY2024 Q3 | 10-Q | Sep 29, 2024 | Oct 31, 2024 | 195 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 2, 2024 | 170 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 3, 2024 | 173 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 23, 2024 | 525 | Open |
Financial data
862 concepts · 19,280 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial800 concepts · 15,402 facts · Jun 2007 to Aug 2026
- Gross profit (US GAAP)88 · Dec 2009 to Jun 2026
- Net income loss88 · Dec 2009 to Jun 2026
- Operating income loss88 · Dec 2009 to Jun 2026
- Revenue87 · Dec 2009 to Jun 2026
- Earnings per share basic85 · Dec 2009 to Jun 2026
- Earnings per share diluted85 · Dec 2009 to Jun 2026
- Income loss from continuing operations including portion attributable to noncontrolling interest85 · Dec 2009 to Jun 2026
- Income loss from continuing operations per basic share85 · Dec 2009 to Jun 2026
- Income loss from continuing operations per diluted share85 · Dec 2009 to Jun 2026
- Income loss from discontinued operations net of tax85 · Dec 2009 to Jun 2026
- Income loss from discontinued operations net of tax per diluted share85 · Dec 2009 to Jun 2026
- Income loss from discontinued operations net of tax per basic share84 · Dec 2009 to Jun 2026
- Cash and cash equivalents at carrying value83 · Dec 2008 to Jun 2026
- Amortization of intangible assets80 · Dec 2009 to Jun 2026
- Income tax expense benefit80 · Dec 2009 to Jun 2026
- Increase decrease in income taxes80 · Dec 2009 to Jun 2026
- Investment income interest80 · Dec 2009 to Jun 2026
- Payments to acquire property plant and equipment80 · Dec 2009 to Jun 2026
- Research and development expense80 · Dec 2009 to Jun 2026
- Selling general and administrative expense80 · Dec 2009 to Jun 2026
- Amortization of financing costs and discounts79 · Dec 2009 to Jun 2026
- Assets79 · Dec 2010 to Jun 2026
- Deferred income tax expense benefit79 · Dec 2009 to Jun 2026
- Depreciation79 · Dec 2009 to Jun 2026
Segment29 concepts · 2,373 facts · Dec 2009 to Jun 2026
- Revenue426 · Dec 2009 to Jun 2026
- Goodwill334 · Dec 2010 to Jun 2026
- Depreciation and amortization228 · Mar 2011 to Jun 2026
- Operating income loss215 · Jun 2013 to Sep 2024
- Goodwill foreign currency translation gain loss174 · Apr 2017 to Jun 2026
- Restructuring charges171 · Mar 2014 to Dec 2018
- Operating Income130 · Jul 2012 to Sep 2024
- Operating segments127 · Apr 2012 to Jun 2026
- Goodwill acquired during period105 · Dec 2011 to Dec 2020
- Restructuring and other impairment charges73 · Apr 2012 to Dec 2015
- Payments to acquire property plant and equipment67 · Dec 2010 to Mar 2013
- Goodwill translation adjustments64 · Dec 2010 to Sep 2016
- Cost of goods and services sold (US GAAP)42 · Dec 2022 to Jun 2026
- Research and development expense42 · Dec 2022 to Jun 2026
- Selling general and administrative expense42 · Dec 2022 to Jun 2026
- Goodwill purchase accounting adjustments34 · Mar 2013 to Jun 2026
- Goodwill other increase decrease14 · Sep 2021 to Dec 2024
- Accounts Receivable, Net13 · Dec 2011 to Dec 2017
- Americas Segment10 · Apr 2012 to Dec 2012
- Gross profit (US GAAP)10 · Mar 2011 to Apr 2012
- Goodwill written off related to sale of business unit9 · Dec 2010 to Dec 2021
- Revenue from contracts with customers (excluding tax)9 · Jul 2017 to Apr 2018
- Goodwill impairment loss8 · Mar 2012 to Dec 2012
- Total Assets8 · Mar 2011 to Dec 2012
Geography19 concepts · 916 facts · Dec 2009 to Dec 2025
- Revenue292 · Dec 2009 to Dec 2025
- Property, Plant & Equipment, Net118 · Dec 2010 to Dec 2025
- Depreciation and amortization86 · Dec 2010 to Mar 2014
- Goodwill acquired during period70 · Dec 2012 to Dec 2019
- Operating segments62 · Dec 2010 to Mar 2014
- Goodwill foreign currency translation gain loss44 · Dec 2015 to Dec 2019
- Revenues from transactions with other operating segments of same entity42 · Dec 2010 to Dec 2012
- Restructuring and other impairment charges38 · Dec 2011 to Mar 2014
- Payments to acquire property plant and equipment36 · Dec 2011 to Dec 2013
- Goodwill translation adjustments35 · Dec 2012 to Dec 2015
- Goodwill31 · Dec 2013 to Dec 2019
- Total Assets24 · Jul 2012 to Dec 2013
- Operating income loss16 · Jul 2012 to Sep 2013
- Spain, Italy, Portugal, and Greece13 · Dec 2012 to Dec 2017
- Goodwill purchase accounting adjustments3 · Dec 2012 to Sep 2013
- Americas Segment2 · Dec 2012
- Financing receivable significant sales2 · Dec 2018
- Goodwill impairment loss1 · Dec 2012
- Goodwill written off related to sale of business unit1 · Dec 2012
Product2 concepts · 327 facts · Apr 2017 to Jun 2026
- Revenue319 · Apr 2017 to Jun 2026
- Asset impairment charges8 · Mar 2025 to Dec 2025
Guidance12 concepts · 262 facts · Feb 2012 to Aug 2026
- Revenue Growth Guidance70 · Feb 2012 to Aug 2026
- EPS (Diluted) Guidance68 · Feb 2012 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))46 · Feb 2015 to Aug 2026
- Revenue Growth Guidance (Constant currency)46 · Feb 2015 to Apr 2021
- EPS (Diluted) Growth Guidance (Adjusted (non-GAAP))18 · Apr 2015 to Feb 2021
- EPS (Diluted) Growth Guidance (from continuing operations; Adjusted (non-GAAP))2 · Oct 2019
- EPS (Diluted) Guidance (from continuing operations)2 · Oct 2019
- EPS (Diluted) Guidance (from continuing operations; Adjusted (non-GAAP))2 · Oct 2019
- Operating Margin Guidance (Adjusted (non-GAAP))2 · Aug 2026
- Revenue Growth Guidance (Adjusted, constant currency)2 · Aug 2026
- Revenue Guidance2 · Aug 2026
- Revenue Guidance (Adjusted (non-GAAP))2 · Aug 2026
Segments
3,616 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments53 members · 2,373 facts
- Asia342 · Apr 2012 to Jun 2026
- EMEA330 · Dec 2012 to Jun 2026
- Americas183 · Apr 2012 to Jun 2026
- Oem183 · Apr 2012 to Dec 2023
- Vascular North America161 · Dec 2012 to Sep 2020
- All Other Segments124 · Dec 2012 to Dec 2018
- Surgical North America123 · Dec 2012 to Dec 2018
- Emea100 · Dec 2011 to Jun 2026
- Asia95 · Jul 2012 to Jun 2026
- Anesthesia North America88 · Jun 2014 to Dec 2018
- Reportable Segments86 · Dec 2010 to Mar 2013
- Oemsegment76 · Dec 2011 to Sep 2024
- Americas segment55 · Jul 2012 to Jun 2026
- Anesthesia Respiratory North America54 · Dec 2012 to Dec 2016
- Interventional North America44 · Dec 2015 to Dec 2018
- OEM43 · Mar 2020 to Sep 2024
- Vascular north america28 · Dec 2013 to Sep 2020
- Emea26 · Dec 2011 to Mar 2013
- North America20 · Dec 2011 to Dec 2012
- Surgical north america20 · Dec 2013 to Sep 2018
- All other segments17 · Dec 2013 to Sep 2018
- Anesthesia north america15 · Dec 2014 to Sep 2018
- Emeasegment15 · Dec 2011 to Dec 2025
- Corporate14 · Dec 2022 to Jun 2026
- Asia segment14 · Dec 2012 to Dec 2025
- Spain italy portugal and greece13 · Dec 2011 to Dec 2017
- Reportable Corporate11 · Dec 2010 to Dec 2012
- Oem segment10 · Dec 2011 to Dec 2023
- Reportable segments8 · Mar 2011 to Dec 2012
- Ajla7 · Dec 2011 to Dec 2012
- Medical6 · Dec 2010 to Dec 2011
- Ajla segment6 · Dec 2011 to Dec 2012
- Anesthesia respiratory north america6 · Dec 2013 to Mar 2015
- North america segment6 · Dec 2011 to Dec 2012
- Spain Italy Portugal And Greece5 · Dec 2010 to Dec 2012
- Former Commercial4 · Dec 2010 to Dec 2011
- Americas4 · Jul 2012 to Sep 2013
- Interventional north america4 · Dec 2017 to Sep 2018
- Cardiac Care3 · Dec 2009 to Dec 2011
- Critical Care3 · Dec 2009 to Dec 2011
- Oem And Development Services3 · Dec 2009 to Dec 2011
- Other3 · Dec 2009 to Dec 2011
- Surgical Care3 · Dec 2009 to Dec 2011
- Italian Government2 · Sep 2012
- Spanish Government2 · Jun 2012 to Jul 2012
- Anesthesia Respiratory Reporting Unit1 · Mar 2012
- Cardiac Reporting Unit1 · Mar 2012
- Former commercial segment1 · Dec 2010
- Interventional urology north america1 · Jun 2025
- Medical1 · Dec 2011
- Medical segment1 · Dec 2010
- Oem1 · Sep 2012
- Vascular Reporting Unit1 · Mar 2012
Statement geographicalus-gaap:StatementGeographicalAxis44 members · 795 facts
- EMEA71 · Dec 2011 to Dec 2017
- Asia66 · Dec 2011 to Apr 2018
- Americas55 · Dec 2011 to Dec 2013
- Oem51 · Dec 2011 to Dec 2017
- All Other43 · Dec 2009 to Apr 2018
- Segment Geographical Groups Of Countries Group Four38 · Dec 2010 to Dec 2012
- Segment Geographical Groups Of Countries Group One38 · Dec 2010 to Dec 2012
- Segment Geographical Groups Of Countries Group Two38 · Dec 2010 to Dec 2012
- Segment Geographical Groups Of Countries Group Three36 · Dec 2010 to Dec 2012
- All other32 · Dec 2010 to Dec 2025
- Us24 · Dec 2010 to Dec 2025
- Spain Italy Portugal And Greece24 · Dec 2011 to Dec 2017
- US23 · Dec 2009 to Apr 2018
- Other Americas21 · Dec 2009 to Dec 2017
- My18 · Dec 2013 to Dec 2024
- Europe17 · Dec 2012 to Apr 2018
- Surgical North America15 · Mar 2013 to Dec 2017
- Vascular North America15 · Mar 2013 to Dec 2017
- Anesthesia Respiratory North America13 · Mar 2013 to Dec 2016
- Concentration Countries Greece Italy Spain And Portugal12 · Mar 2015 to Apr 2018
- Cz12 · Dec 2013 to Dec 2018
- De9 · Dec 2010 to Dec 2025
- DE9 · Dec 2009 to Jun 2014
- Other Europe9 · Dec 2009 to Jun 2014
- Concentration Countries Gr It Spand Po8 · Mar 2014 to Sep 2015
- Ie7 · Dec 2014 to Dec 2020
- Other americas7 · Dec 2010 to Jun 2014
- Other europe7 · Dec 2010 to Jun 2014
- Vascular north america7 · Dec 2013 to Dec 2019
- Anesthesia Respiratory6 · Mar 2013 to Mar 2014
- Surgical6 · Mar 2013 to Mar 2014
- Oem6 · Jul 2012 to Dec 2013
- Surgical north america6 · Dec 2013 to Dec 2018
- Americas6 · Jul 2012 to Dec 2013
- Asia6 · Jul 2012 to Dec 2013
- Emea6 · Jul 2012 to Dec 2013
- Vascular6 · Mar 2013 to Mar 2014
- Anesthesia North America4 · Dec 2016 to Dec 2017
- Interventional North America4 · Dec 2016 to Dec 2017
- Anesthesia respiratory north america4 · Dec 2013 to Dec 2016
- ESITPT And GR3 · Sep 2013 to Sep 2014
- Anesthesia north america3 · Dec 2016 to Dec 2018
- Interventional north america3 · Dec 2016 to Dec 2018
- Original Equipment Manufacturer And Development Services1 · Dec 2012
Product or servicesrt:ProductOrServiceAxis9 members · 313 facts
- Surgical46 · Jul 2017 to Jun 2026
- Vascular Access46 · Jul 2017 to Jun 2026
- Interventional45 · Jul 2017 to Jun 2026
- Anesthesia42 · Jul 2017 to Sep 2025
- Interventional Urology42 · Jul 2017 to Sep 2025
- Oem42 · Jul 2017 to Sep 2025
- Other42 · Jul 2017 to Dec 2025
- Titan SGS6 · Mar 2025 to Dec 2025
- Certain Leased Facilities2 · Dec 2025
Statement geographicalsrt:StatementGeographicalAxis19 members · 121 facts
- All Other20 · Dec 2016 to Dec 2025
- Europe16 · Dec 2016 to Dec 2025
- US16 · Dec 2016 to Dec 2025
- Asia10 · Jul 2017 to Dec 2019
- Asia And Asia Pacific9 · Dec 2017 to Dec 2025
- Mx6 · Dec 2020 to Dec 2025
- EMEA6 · Dec 2017 to Dec 2019
- Oem6 · Dec 2017 to Dec 2019
- Vascular North America6 · Dec 2017 to Dec 2019
- Anesthesia North America4 · Dec 2017 to Dec 2018
- Interventional North America4 · Dec 2017 to Dec 2018
- Surgical North America4 · Dec 2017 to Dec 2018
- Other Americas3 · Dec 2016 to Dec 2018
- Spain Italy Portugal And Greece3 · Dec 2016 to Dec 2018
- Concentration Countries Greece Italy Spain And Portugal2 · Oct 2017 to Sep 2018
- Ch2 · Dec 2024 to Dec 2025
- Czk2 · Dec 2024 to Dec 2025
- IT1 · Dec 2018
- PT1 · Dec 2018
Product or serviceus-gaap:ProductOrServiceAxis7 members · 14 facts
- Anesthesia2 · Apr 2017 to Apr 2018
- Interventional2 · Apr 2017 to Apr 2018
- Interventional Urology2 · Apr 2017 to Apr 2018
- Oem2 · Apr 2017 to Apr 2018
- Other2 · Apr 2017 to Apr 2018
- Surgical2 · Apr 2017 to Apr 2018
- Vascular Access2 · Apr 2017 to Apr 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary70 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary166 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes6 claims from 1 reports · Dec 2025
- Risk factors68 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.